Authorize the first home test to detect Covid-19

The United States FDA authorizes the use of Lucira for emergencies, the first home test to detect Coronavirus Covid-19 in 30 minutes.

In the fight against Coronavirus Covid-19 there are multiple fronts open simultaneously. Yes an important goal is to find a cure or vaccine.

But it is also essential to be able to detect each case of infection in time to reduce the risk of increasing the number of patients.

That’s where Lucira Health came to shake the ground, creating a home test that, in theory, could give an almost accurate result in just 30 minutes.

The FDA authorizes this home test

Through a statement on its official website, the United States Food and Drug Administration (FDA) shares that it has approved the use of this home test. But only for emergency situations.

Such kind of conditioner, for the regulatory rules in force in the United States, would oblige that the Lucira Health rapid test can only be acquired by prescription. What would limit its distribution and initial access.

This new approved Kit, called Lucira COVID-19 All-In-One, allows users to take a nasal sample themselves.

The swab is then rubbed with the sample in a solution and deposited into the conduit of the testing device.

After 30 minutes or less an LED on the device will indicate whether the sample is positive or not in the presence of SARS-CoV-2.

Its effectiveness rate would be close to 94%, but there is a restriction that it could only be used in people over 14 years of age.

This is an important advance, considering that it currently takes entire days to receive the results of a test for this Coronavirus.